Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.

Pasquier F, Sadowsky C, Holstein A, Leterme GLe Prince, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, J Ryan M, et al.
J Alzheimers Dis. 2016; 51(4):1131-43. PMID: 26967206. Abstract